ATS 2020 Advance Program

Target Audience This session is of interest to trainees and clinicians who care for critically ill cancer patients as well as decision-makers adapting health care delivery systems in North America and abroad. Objectives At the conclusion of this session, the participant will be able to: • understand the complexities of prognostication in cancer critical care; • strengthen systems for delivering critical care to cancer patients at their home institution; • initiate management for several specialized medical problems among critically ill cancer patients. As cancer treatment rapidly evolves, there is burgeoning interest among critical care providers to deepen knowledge specific to delivering expert and optimal care to cancer patients. This symposium comprehensively addresses information needed to advance our care of critically ill cancer patients, including resource allocation, systems of health care delivery, clinical needs specific to this growing population, and emerging science in the oncology field that translates to critical illness. Chairing: L. Munshi, MD, Toronto, Canada R.S. Stephens, MD, Baltimore, MD 9:15 Critical Care for All, Some, or None? E. Azoulay, MD, PhD, Paris, France 9:30 PRO: The Gains of Oncology-Dedicated ICUs Are Worth the Costs S.M. Pastores, MD, New York, NY 9:45 CON: The Costs of Oncology-Dedicated ICUs Outweigh the Gains J.M. Kahn, MD, MSc, Pittsburgh, PA 10:00 What an Oncologist Would Like an Intensivist to Know A. DeZern, MD, MHS, Baltimore, MD 10:15 Critical Illness and the Oncology Patient: Are We Speaking the Same Biological Language? R.S. Stephens, MD, Baltimore, MD 10:30 Respiratory Failure: Should This Common ICU Admission Be Approached Differently in Immunocompromised Patients? L. Munshi, MD, Toronto, Canada 10:45 Immunotherapies: Advances and Toxicities Encountered in Critical Care C. Gutierrez, MD, Houston, TX 11:00 Unleashing the Immune System: Immunotherapies and Stem Cell Transplant for Sepsis - What We Have Learned from Oncology P. Torabi-Parizi, MD, Bethesda, MD BASIC • TRANSLATIONAL BASIC SCIENCE CORE A5 LUNG REGENERATION: WHAT DO WE WANT? 9:15 a.m. - 11:15 a.m. Target Audience Basic and translational scientists as well as providers who manage patients with chronic and end stage lung disease Objectives At the conclusion of this session, the participant will be able to: • learn new findings about lung regeneration; • apply new techniques for studying lung regeneration in model systems; • gain a current understanding of the roles that stem and progenitor cells as well as the mesenchyme can serve in lung regeneration. In this first of two thematically linked basic science core sessions, the topic of lung regeneration will be introduced and recent progress in the field will be highlighted. In particular, three main subject areas will be addressed: a) Rebuilding a Lung: Bioengineered Lungs and Cell Replacement Strategies b) Identification and Characterization of Regenerative Cells: Endogenous Compartmental Stem Cells and Exogenous Progenitor Cells c) Discovery of Lung Regenerative Cocktails (Beyond Anti-Inflammatory Strategies): Growth Factors ATS 2020 • Philadelphia, PA 38 SUNDAY • MAY 17